| HOME >> MEDICINE >> TECHNOLOGY |
0.26$
0.12$
0.46$
0.31Diluted
$
0.24$
0.12$
0.42$
0.30Weighted average number of shares outstanding: Basic 14,793,77514,332,73114,639,46414,322,786Diluted 16,394,90214,342,16816,309,91114,445,374NUTRASTAR INTERNATIONAL INC. and subsidiariesCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)(AMOUNTS EXPRESSED IN US DOLLARS)For the Six Months EndedJune 30,20112010CASH FLOWS FROM OPERATING ACTIVITIES:Net income
$
6,909,388
$
6,136,703Adjustments to reconcile net income to cash provided by operating activities:Change in fair value of warrants(829,125)(131,088)IR warrants and consultant restricted stock expense41,526-Depreciation and amortization546,552506,125Share-based compensation expense181,571105,875(Increase) decrease in assets:Accounts receivable 25,099(62,578)Prepayments and other receivables(828,948)41,662Inventories(1,150,108)(84,617)Increase (decrease) in liabilities:Accounts payable(112,813)54,073Other payables and accruals44,378(75,431)Taxes payable1,173,734(80,193)Net cash provided by operating activities6,001,2546,410,531CASH FLOWS FROM INVESTING ACTIVITIES:Purchase of property, plant and equipment(1,950,448)(8,246)Net cash used in investing activities(1,950,448)(8,246)CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from private placement-5,483,919Decrease (increase) in restricted cash92,815(350,000)Advance from related party-436,047Net cash provided by financing activities92,8155,569,966Foreign currency translation adjustment914,415174,315INCREASE IN CASH AND CASH EQUIVALENTS5,058,03612,146,566CASH AND CASH EQUIVALENTS, at the beginning of the period40,758,84820,115,677CASH AND CASH EQUIVALENTS, at the end of the period$ 45,816,884$32,262,243NON-CASH TRANSACTIONSPreferred stock and dividend converted into common stock
$
1,123,305
$
-Preferred stock dividend payable322,595181,181Share-based payment – IR warrants and consultant r
'/>"/>
| SOURCE Nutrastar International Inc. Copyright©2010 PR Newswire. All rights reserved |